Daily Summary
The FDA has approved a new drug called TNKase (tenecteplase) for treating acute ischemic stroke in adults. This drug works by dissolving blood clots, offering a fresh treatment option for stroke patients.
FDA Approves TNKase for Acute Ischemic Stroke
The FDA has approved TNKase (tenecteplase) for treating acute ischemic stroke in adults, providing a fast, single-bolus alternative for dissolving blood clots.